LEXICON PHARMACEUTICALS, INC. financial data

Symbol
LXRX on Nasdaq
Location
The Woodlands, TX
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 327% % -64%
Quick Ratio 0.43% % -71%
Debt-to-equity 90% % 39%
Return On Equity -42% % 55%
Return On Assets -22% % 61%
Operating Margin -98% % 85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 423,680,611 shares 17%
Common Stock, Shares, Outstanding 365,848,216 shares 0.78%
Entity Public Float $170,000,000 USD -43%
Common Stock, Value, Issued $366,000 USD 0.83%
Weighted Average Number of Shares Outstanding, Basic 363,053,000 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 363,053,000 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $49,803,000 USD 60%
Revenue from Contract with Customer, Excluding Assessed Tax $6,170,000 USD 180%
Research and Development Expense $61,121,000 USD -28%
Costs and Expenses $98,714,000 USD -57%
Operating Income (Loss) $48,911,000 USD 75%
Net Income (Loss) Attributable to Parent $50,341,000 USD 75%
Earnings Per Share, Basic -0.14 USD/shares 78%
Earnings Per Share, Diluted -0.14 USD/shares 78%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $34,326,000 USD -49%
Accounts Receivable, after Allowance for Credit Loss, Current $2,384,000 USD -31%
Inventory, Net $281,000 USD 22%
Other Assets, Current $3,000,000 USD -34%
Assets, Current $101,895,000 USD -59%
Property, Plant and Equipment, Net $1,863,000 USD -25%
Operating Lease, Right-of-Use Asset $7,318,000 USD 51%
Goodwill $44,543,000 USD 0%
Other Assets, Noncurrent $368,000 USD 0%
Assets $184,987,000 USD -38%
Accounts Payable, Current $3,083,000 USD -79%
Employee-related Liabilities, Current $6,415,000 USD -56%
Accrued Liabilities, Current $13,189,000 USD -57%
Contract with Customer, Liability, Current $4,303,000 USD
Liabilities, Current $20,867,000 USD -54%
Operating Lease, Liability, Noncurrent $6,592,000 USD 43%
Other Liabilities, Noncurrent $7,174,000 USD 3.6%
Liabilities $77,449,000 USD -49%
Accumulated Other Comprehensive Income (Loss), Net of Tax $30,000 USD -75%
Retained Earnings (Accumulated Deficit) $2,017,583,000 USD -2.6%
Stockholders' Equity Attributable to Parent $107,538,000 USD -26%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $107,538,000 USD -26%
Liabilities and Equity $184,987,000 USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $43,778,000 USD 21%
Net Cash Provided by (Used in) Financing Activities $572,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $40,582,000 USD
Common Stock, Shares Authorized 450,000,000 shares 0%
Common Stock, Shares, Issued 365,848,216 shares 0.78%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,768,000 USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $63,326,000 USD -5%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,968,000 USD -8.9%
Deferred Tax Assets, Valuation Allowance $431,039,000 USD 2.4%
Deferred Tax Assets, Gross $432,816,000 USD 2.5%
Operating Lease, Liability $8,234,000 USD 43%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $50,430,000 USD 75%
Lessee, Operating Lease, Liability, to be Paid $11,645,000 USD 35%
Property, Plant and Equipment, Gross $4,570,000 USD 0%
Operating Lease, Liability, Current $1,642,000 USD 40%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,683,000 USD 95%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,649,000 USD 35%
Operating Lease, Weighted Average Discount Rate, Percent 0.105 Rate 8.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,411,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,718,000 USD 95%
Deferred Tax Assets, Operating Loss Carryforwards $326,625,000 USD 3.4%
Preferred Stock, Shares Issued 2,304,147 shares 0%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,753,000 USD 95%
Additional Paid in Capital $2,129,912,000 USD 0.59%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $176,000 USD 22%
Share-based Payment Arrangement, Expense $12,500,000 USD -7.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%